INFLUENZA A VIRUS INFECTION
Clinical trials for INFLUENZA A VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA A VIRUS INFECTION trials appear
Sign up with your email to follow new studies for INFLUENZA A VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New flu pill TRX-100 tested for safety and symptom relief
Symptom relief OngoingThis early-stage study tests different doses of an experimental flu medicine called TRX-100, taken alongside standard care, in 105 people with mild to moderate influenza. The main goals are to check safety and find the best dose. Researchers will also track how well it eases flu …
Matched conditions: INFLUENZA A VIRUS INFECTION
Phase: PHASE2 • Sponsor: Traws Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Experimental device trial: what you need to know
Knowledge-focused WITHHELDThis trial is studying a device that has not been approved by the U.S. FDA. The purpose is to gather information about how the device works and its safety. Participants will be monitored closely. The study sponsor and current status are not publicly available.
Matched conditions: INFLUENZA A VIRUS INFECTION
Sponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC